Schleiss MR - Search Results

1

Lack of induction of autoantibody responses following immunization with cytomegalovirus (CMV) glycoprotein B (gB) in healthy CMV-seronegative subjects.

Schleiss MR, Bernstein DI, Passo M, Parker S, Meric C, Verdier F, Newkirk MM. Schleiss MR, et al. Vaccine. 2004 Dec 16;23(5):687-92. doi: 10.1016/j.vaccine.2004.06.038. Vaccine. 2004. PMID: 15542191 Clinical Trial.

2

Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs.

Bratcher DF, Bourne N, Bravo FJ, Schleiss MR, Slaoui M, Myers MG, Bernstein DI. Bratcher DF, et al. Among authors: schleiss mr. J Infect Dis. 1995 Oct;172(4):944-50. doi: 10.1093/infdis/172.4.944. J Infect Dis. 1995. PMID: 7561214

3

DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2.

Bourne N, Milligan GN, Schleiss MR, Bernstein DI, Stanberry LR. Bourne N, et al. Among authors: schleiss mr. Vaccine. 1996 Sep;14(13):1230-4. doi: 10.1016/s0264-410x(96)00027-8. Vaccine. 1996. PMID: 8961510

4

Identification and characterization of the guinea-pig cytomegalovirus glycoprotein H gene.

Brady RC, Schleiss MR. Brady RC, et al. Among authors: schleiss mr. Arch Virol. 1996;141(12):2409-24. doi: 10.1007/BF01718640. Arch Virol. 1996. PMID: 9526546

5

An adolescent with nephrotic syndrome and multiple leg nodules.

Brady RC, Strife CF, Sheth AP, Passo M, Schleiss MR. Brady RC, et al. Among authors: schleiss mr. Pediatr Infect Dis J. 1998 Nov;17(11):1057-8, 1061-3. doi: 10.1097/00006454-199811000-00025. Pediatr Infect Dis J. 1998. PMID: 9849998 No abstract available.

6

Immunogenicity evaluation of DNA vaccines that target guinea pig cytomegalovirus proteins glycoprotein B and UL83.

Schleiss MR, Bourne N, Jensen NJ, Bravo F, Bernstein DI. Schleiss MR, et al. Viral Immunol. 2000;13(2):155-67. doi: 10.1089/vim.2000.13.155. Viral Immunol. 2000. PMID: 10892996

7

Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection.

Bourne N, Schleiss MR, Bravo FJ, Bernstein DI. Bourne N, et al. Among authors: schleiss mr. J Infect Dis. 2001 Jan 1;183(1):59-64. doi: 10.1086/317654. Epub 2000 Nov 21. J Infect Dis. 2001. PMID: 11087203

8

Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults.

Bernstein DI, Schleiss MR, Berencsi K, Gonczol E, Dickey M, Khoury P, Cadoz M, Meric C, Zahradnik J, Duliege AM, Plotkin S. Bernstein DI, et al. Among authors: schleiss mr. J Infect Dis. 2002 Mar 1;185(5):686-90. doi: 10.1086/339003. Epub 2002 Feb 6. J Infect Dis. 2002. PMID: 11865427 Clinical Trial.

9

Cloning and expression of the guinea pig cytomegalovirus glycoprotein B (gB) in a recombinant baculovirus: utility for vaccine studies for the prevention of experimental infection.

Schleiss MR, Jensen NJ. Schleiss MR, et al. J Virol Methods. 2003 Mar;108(1):59-65. doi: 10.1016/s0166-0934(02)00258-6. J Virol Methods. 2003. PMID: 12565154

10

Quantitative-competitive PCR monitoring of viral load following experimental guinea pig cytomegalovirus infection.

Schleiss MR, Bourne N, Bravo FJ, Jensen NJ, Bernstein DI. Schleiss MR, et al. J Virol Methods. 2003 Mar;108(1):103-10. doi: 10.1016/s0166-0934(02)00265-3. J Virol Methods. 2003. PMID: 12565160

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters